Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation

Rationale Despite the critical role attributed to phosphorylated
extracellular signal regulated kinase (pERK1/2) in the nucleus
accumbens (Acb) in the actions of addictive drugs, the effects of morphine on ERK1/2 phosphorylation in this area are still controversial.
Objectives In order to investigate further this issue,we studied
(1) the ability of morphine to affect ERK1/2 phosphorylation in
the shell (AcbSh) and core (AcbC) of Sprague-Dawley and Wistar rats and of CD-1 and C57BL/6J mice and (2) the role of dopamine D1 and μ-opioid receptors in Sprague-Dawley rats and CD-1 mice. Methods The pERK1/2 expression was assessed by
immunohistochemistry.
Results In rats, morphine decreased AcbSh and AcbC pERK1/2 expression, whereas in mice, increased it preferentially in the AcbSh compared with the AcbC. Systemic SCH 39166 decreased pERK1/2 expression on its own in the AcbSh and AcbC of Sprague-Dawley rats and CD-1 mice; furthermore,in rats, SCH 39166 disclosed the ability of morphine to stimulate pERK1/2 expression. Systemic (rats and mice) and intra-
Acb (rats) naltrexone prevented both decreases, in rats, and increases, in mice. Conclusions These findings confirm the differential effects of
morphine in rats and mice Acb and that D1 receptors exert a
facilitatory role on ERK1/2 phosphorylation; furthermore, they
indicate that, in rats, removal of the D1-dependent pERK1/2
expression discloses the stimulatory influence of morphine on
ERK1/2 phosphorylation and that the morphine’s ability to decrease pERK1/2 expression is mediated by Acb μ-opioid receptors. Future experiments may disentangle the psychopharmacological
significance of the effects of morphine on pERK1/2 in the Acb.